Influence of Short-Term Treatment with Simvastatin 40 Mg on Plasma Concentration of High-Sensitivity C-reactive Protein in Patients with Unstable Angina Pectoris
LI Qiang,LIU Jia-mei,WANG Zhe,SHI Lin-ying,LI Yan-hui,XU Lin,YANG Xin-chun
DOI: https://doi.org/10.3969/j.issn.1004-583x.2007.21.002
2007-01-01
Abstract:Objective To study the changes of plasma high-sensitivity C-reactive protein(hs-CRP) concentrations in the patients with unstable angina pectoris(UAP) after two-weeks' treatment with simvastatin 20 mg or 40 mg per day,and explore the influence of aggressive lipid-lowering therapy on hs-CRP in short term.Methods Seventy-six UAP cases were randomly divided into two groups to accept simvastatin 20 mg per day as routine lipid-lowering group(ROU group,n=38),or simvastatin 40 mg per day as aggressive lipid-lowering group(AGG group,n=38) at the base of routine therapy.The concentrations of LDL cholesterol(LDL-C),HDL-C,TC,TG and hs-CRP of all the patients were measured before and one week and two weeks after therapy.Results Both TC and LDL-C could be decreased by simvastatin(20 mg or 40 mg daily) therapy through two weeks(TC:F=44.88,P0.0001;LDL-C:F=32.92,P0.0001).The plasma hs-CRP concentration had descendent trend in two groups(F=4.515,P=0.044).And,hs-CRP had more significant decrease in AUG group than that in ROU group.The reduction of plasma hs-CRP concentration was not related to the change of plasma lipid level.Conclusion Simvastatin 40 mg may effectively reduce the plasma hs-CRP concentrations in UAP patients by two weeks independent on its effect for TC,HDL-C,LDL-C and TG.